Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080963256> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2080963256 endingPage "S171" @default.
- W2080963256 startingPage "S171" @default.
- W2080963256 abstract "No meta-analysis has analysed efficacy and safety of remogliflozin. We undertook this meta-analysis to address this gap in knowledgeElectronic databases were searched for RCTs involving diabetes patients receiving remogliflozin as compared to controls. Primary outcome was to evaluate changes in HbA1c. Secondary outcomes were to evaluate alterations in glycaemia, lipids and adverse events.Data from 3 RCTs involving 535 patients was analysed [2 having pioglitazone and 1 having dapagliflozin as active comparator]. Over 12–24 weeks use, Hba1c [mean difference (MD) −0.13% (95% CI: 0.35 – 0.09%); P = 0.24; I2 = 99%] and fasting glucose [MD 3.67 mg/dl (95% CI: 0.53 – 7.88 mg/dl); P = 0.09; I2 = 52%]. reduction with remogliflozin was not significantly different from controls. Remogliflozin was inferior to dapagliflozin with regards to reduction in post-prandial glucose [MD+12.17 mg/dl (95%CI:10.79–13.55 mg/dl); P < 0.001].Remogliflozin use was associated with a significantly greater decline in body weight [MD -2.79 kg (95% CI: 3.07 to −2.51 kg); P < 0.001; I2 = 30%]. Total adverse events [Risk ratio (RR) 1.21 (95% CI: 0.62–2.64); P = 0.58; I2 = 59%] were comparable among groups.Remogliflozin had HbA1c and fasting glucose reduction comparable to pioglitazone and dapagliflozin. The paradox with regard to post-prandial glucose reduction needs further evaluation. The current analysis is limited by considerable data heterogeneity and low certainty of evidence for most primary and secondary outcomes. There remains urgent need for high quality RCTs evaluating long-term outcomes with remogliflozin." @default.
- W2080963256 created "2016-06-24" @default.
- W2080963256 creator A5016176374 @default.
- W2080963256 creator A5023206770 @default.
- W2080963256 creator A5026943170 @default.
- W2080963256 creator A5038984237 @default.
- W2080963256 creator A5047301288 @default.
- W2080963256 creator A5050996534 @default.
- W2080963256 creator A5064910245 @default.
- W2080963256 creator A5080842007 @default.
- W2080963256 date "2008-08-01" @default.
- W2080963256 modified "2023-09-26" @default.
- W2080963256 title "S.08.04 Cannabidiol as antipsychotic" @default.
- W2080963256 doi "https://doi.org/10.1016/s0924-977x(08)70156-1" @default.
- W2080963256 hasPublicationYear "2008" @default.
- W2080963256 type Work @default.
- W2080963256 sameAs 2080963256 @default.
- W2080963256 citedByCount "0" @default.
- W2080963256 crossrefType "journal-article" @default.
- W2080963256 hasAuthorship W2080963256A5016176374 @default.
- W2080963256 hasAuthorship W2080963256A5023206770 @default.
- W2080963256 hasAuthorship W2080963256A5026943170 @default.
- W2080963256 hasAuthorship W2080963256A5038984237 @default.
- W2080963256 hasAuthorship W2080963256A5047301288 @default.
- W2080963256 hasAuthorship W2080963256A5050996534 @default.
- W2080963256 hasAuthorship W2080963256A5064910245 @default.
- W2080963256 hasAuthorship W2080963256A5080842007 @default.
- W2080963256 hasConcept C118552586 @default.
- W2080963256 hasConcept C126322002 @default.
- W2080963256 hasConcept C134018914 @default.
- W2080963256 hasConcept C142724271 @default.
- W2080963256 hasConcept C197934379 @default.
- W2080963256 hasConcept C204787440 @default.
- W2080963256 hasConcept C27081682 @default.
- W2080963256 hasConcept C2776895053 @default.
- W2080963256 hasConcept C2777056318 @default.
- W2080963256 hasConcept C2777180221 @default.
- W2080963256 hasConcept C2777422806 @default.
- W2080963256 hasConcept C2778384471 @default.
- W2080963256 hasConcept C2909688399 @default.
- W2080963256 hasConcept C555293320 @default.
- W2080963256 hasConcept C71924100 @default.
- W2080963256 hasConcept C95190672 @default.
- W2080963256 hasConceptScore W2080963256C118552586 @default.
- W2080963256 hasConceptScore W2080963256C126322002 @default.
- W2080963256 hasConceptScore W2080963256C134018914 @default.
- W2080963256 hasConceptScore W2080963256C142724271 @default.
- W2080963256 hasConceptScore W2080963256C197934379 @default.
- W2080963256 hasConceptScore W2080963256C204787440 @default.
- W2080963256 hasConceptScore W2080963256C27081682 @default.
- W2080963256 hasConceptScore W2080963256C2776895053 @default.
- W2080963256 hasConceptScore W2080963256C2777056318 @default.
- W2080963256 hasConceptScore W2080963256C2777180221 @default.
- W2080963256 hasConceptScore W2080963256C2777422806 @default.
- W2080963256 hasConceptScore W2080963256C2778384471 @default.
- W2080963256 hasConceptScore W2080963256C2909688399 @default.
- W2080963256 hasConceptScore W2080963256C555293320 @default.
- W2080963256 hasConceptScore W2080963256C71924100 @default.
- W2080963256 hasConceptScore W2080963256C95190672 @default.
- W2080963256 hasLocation W20809632561 @default.
- W2080963256 hasOpenAccess W2080963256 @default.
- W2080963256 hasPrimaryLocation W20809632561 @default.
- W2080963256 hasRelatedWork W1994230976 @default.
- W2080963256 hasRelatedWork W2022200982 @default.
- W2080963256 hasRelatedWork W2033522292 @default.
- W2080963256 hasRelatedWork W2042938358 @default.
- W2080963256 hasRelatedWork W2082530614 @default.
- W2080963256 hasRelatedWork W2121496639 @default.
- W2080963256 hasRelatedWork W2135578739 @default.
- W2080963256 hasRelatedWork W2237317573 @default.
- W2080963256 hasRelatedWork W4240196000 @default.
- W2080963256 hasRelatedWork W8919293 @default.
- W2080963256 hasVolume "18" @default.
- W2080963256 isParatext "false" @default.
- W2080963256 isRetracted "false" @default.
- W2080963256 magId "2080963256" @default.
- W2080963256 workType "article" @default.